New chatbot aims to help native americans kick the habit

NCT ID NCT06697496

First seen Jan 03, 2026 · Last updated Jun 19, 2026 · Updated 29 times

Summary

This study is testing two remote programs—a chatbot app called QuitBot and a text messaging service—to help American Indian and Alaska Native adults quit smoking. About 772 participants will be randomly assigned to one of the programs. The goal is to see which approach works better for helping people stay smoke-free and reduce their risk of smoking-related cancers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

QuitBot chatbot and text messaging program

What this could lead to

If successful, this could provide an effective, culturally tailored digital tool to help American Indian and Alaska Native people quit smoking and lower their cancer risk.

What could go wrong

This is a behavioral intervention trial, not a drug or cure. Success depends on engagement, and results may not apply to other populations. The study is not yet recruiting.

Conditions

The condition(s) this trial relates to.

squamous cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.